Skip to search formSkip to main contentSkip to account menu

Plavix

Known as: BMS brand 1 of clopidogrel bisulfate 
a drug that prevents heart attack
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
To study the resistance to standard dosage of clopidogrel among Iranian patients following percutaneous coronary intervention… 
2012
2012
Patients : Étaient inclus les patients âgés de 18 ans ou plus, qui présentaient un SCA (angine instable, infarctus du myocarde… 
2012
2012
Anecdotal reports, noted Dr. Gibson, have placed the number of prescriptions written for the platelet inhibitor ticagrelor… 
2011
2011
The FDA has approved ticagrelor (Brilinta-AstraZeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the… 
2011
2011
®) gilt als Standardmedikation in der Antiplattchentherapie. Das Medikament stellt nur eine Vorstufe eines eigentlichen aktiven… 
Review
2009
Review
2009
To investigate whether stopping clopidogrel on admission and subsequently delaying surgery in patients with hip fracture… 
Review
2007
Review
2007
The recently discovered increased risk of blood clots, leading to myocardial infarction and sudden death beginning six months… 
2007
2007
A 78-yr-old Caucasian man presented with left eye amaurosis fugax that resolved within 3-4 min. He had a past history of… 
2007
2007
In January 2007, the government of Thailand issued compulsory licences for two medicines in an effort to lower prices on drugs… 
2003
2003
With respect to antiplatelet therapy, randomized trials and their meta-analyses 1 indicate benefits of clopidogrel either as an…